Page 45 - Sohini Das

After a slow start, PLI scheme may switch on the afterburners in FY24

Rs 8,083 cr is expected to be disbursed this fiscal

Import of key Chinese medical devices rises up to 152% till Dec FY23

Overall imports decline 8% in first nine months of FY23

Pharma firm Ipca Labs' plant gets 3 observations from US drugs regulator

The observations were followed by the USFDA inspection at the site from April 18 to April 26

Govt approves National Medical Devices Policy 2023, eyes 12% market share

Mansukh Mandaviya, Union health minister, said that the policy has been designed keeping in mind the need to have a holistic policy framework and will accelerate the growth of this sector

Abbott recalls a batch of thyroid disorder drug for labelling error

Thyronorm has no quality issue, mislabeled batch was invoiced in Madhya Pradesh and Telangana: Company

Looking for long-term partner for EV biz: M&M exec director & CEO Jejurikar

"We do not need any funds; we are well-covered at the moment"

Bajaj Auto Q4 results: Revenue up 12%; PAT dips 2% to Rs 1,433 crore

'Export demand sluggishness may have bottomed out'

Serum Institute of India doubles Biocon investment to $300 million

The earlier investment by SILS in BBL was at a valuation of $4.9 billion, and the fresh $150-million investment pushes it up at $6 billion

GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD

Shingrix is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above, says GSK Pharmaceuticals MD Bhushan Akshikar

Paediatricians bat for Covid-19 vaccine for children as cases rise

Doctors say they are seeing an increase in children with Covid infection

Temporary pause in US shipments from Sun Pharma's plant in Mohali

It implies that company has to take corrective action before releasing further batches to the US

Hospitals raise tech bet as India emerges as hub for complex surgeries

Experts say corporate hospitals are estimated to spend anything from 5 to 8 per cent of their top line on acquiring and upgrading technology

Brownfield expansion will give us 1,700 beds: Fortis Healthcare MD & CEO

Now that we have strength in our balance sheet, we can go for inorganic expansion, too, in markets where we are already present, says Dr Ashutosh Raghuvanshi, MD & CEO of Fortis Healthcare

Growing fertility treatment market set to see spike in M&A activity

M&A activity is set to increase in this space, feels industry, and more partnerships between organised players and mom-and-pop shops is in store

Jaguar Land Rover revs up for electric race; can it meet its 2030 target?

JLR aims to become electric-first luxury carmaker, to invest 15 bn pounds over next 5 years

Fortis Healthcare acquires Medeor Hospital for Rs 225 cr, plans expansion

Fortis Healthcare now has around 4000 operational beds across its network

Jaguar Land Rover raises EV drive bill to £15 bn to catch up with peers

Jefferies, in a report this month, noted that JLR had been focusing on improving profit and cash flow with an emphasis on selling higher-margin SUVs

Discounts are back to 2019 levels; is this a good time to buy a car?

Dealers across brands are slashing prices by Rs 20,000 to over Rs 1 lakh, depending car model

Audi sales double in Q1 of calendar year 2023, pre-owned car biz up 50%

Firm said this was the strongest quarter during past six years in India, with SUVs currently contributing over 60% of total sales

India business to boost pharma, after US sales prove to be a mixed bag

Hospitals to recover from sluggish Q3; diagnostics growth rate at pre-Covid levels